ArticleJournal for immunotherapy of cancer2025

A bispecific antibody targeting PD-L1/TNFR2 increases tumor targeting and enhances antitumor efficacy in colorectal cancer.

Xiaozhen Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.